Tech giant Elon.Muskrevealed in an interview on Fab TV about its brain-computer interface company Neuralink The company's latest human experimentation progress. He said the company's ongoing experiments with its first human subject "look positive" and expects to announce the subject's success in controlling cell phones and computers with his mind later this week.
Since its inception, Neuralink has been developing advancedbrain-computer interface technology, aims to help people who are physically unable to operate electronic devices on their own. Last year, the company announced that it had begun recruiting participants for its first human clinical trials, which are aimed at patients with quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS).
According to Musk, Neuralink's first product is named "Telepathy", and patients implanted with the device will be able to operate computers and cell phones through their minds, an innovation that undoubtedly brings great hope to these patients.
"We hope to be able to provide these patients with a whole new way of communicating so that they can regain the ability to interact with the outside world." Musk said in the interview.
Neuralink's research team is currently closely monitoring the results of the first subject's experiment and hopes to announce positive news within the week. If all goes well, this will be a major breakthrough for brain-computer interface technology in humans, and a sign that more paralyzed patients are expected to regain their lives through similar technology in the future.
The realization of this technology will not only change the lives of paralyzed patients, but also open up a new path for the development of brain-computer interface technology. In the future, with the continuous improvement and popularization of the technology, we may be able to witness the birth of more amazing brain-computer interface applications.
This article comes from users or anonymous contributions, does not represent the position of Mass Intelligence; all content (including images, videos, etc.) in this article are copyrighted by the original author. Please refer to this site for the relevant issues involvedstatement denying or limiting responsibilityPlease contact the operator of this website for any infringement of rights (Contact Us) We will handle this as stated. Link to this article: https://dzzn.com/en/2024/3234.html
